1

TherapeuticsMD

#9922

Rank

$16.9M

Marketcap

US United States

Country

TherapeuticsMD
Leadership team

Governor Thomas G. Thompson (Exec. Chairman)

Mr. Hugh O'Dowd M.B.A. (Pres & Director)

Mr. Robert G. Finizio (Co-Founder)

Products/ Services
Biotechnology, Health Care, Medical, Pharmaceutical
Number of Employees
100 - 500
Headquarters
Boca Raton, Florida, United States
Established
2008
Company Registration
SEC CIK number: 0000025743
Revenue
20M - 100M
Traded as
TXMD
Social Media
Overview
Location
Summary
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
History

TherapeuticsMD was founded in 2012 in Boca Raton, Florida as a specialty pharmaceutical company focusing on health supplements and natural hormones for women. In 2016, the company began selling drugs and medical devices in the United States and globally.

Mission
Our mission is to improve the health and well-being of women across the globe by providing innovative, evidence-based solutions and services.
Vision
We envision a world in which all women have access to health care products and services that are safe, effective, and tailored to their individual needs.
Key Team

Mr. Marlan D. Walker J.D. (Gen. Counsel & Secretay)

Dr. Brian A. Bernick F.A.C.O.G., M.D. (Co-Founder,Co-CEO & Chief Medical Officer)

Mr. Mark A. Glickman (Co-CEO & Chief Bus. Officer)

Ms. Daniella Silva (Chief Compliance Officer)

Mr. Michael C. Donegan (Interim CFO, Chief Accounting Officer and Principal Financial & Accounting Officer)

Mr. Benjamin Foulk (VP of HR)

Mr. Mitchell L. Krassan (Exec. VP and Chief Strategy & Performance Officer)

Recognition and Awards
TherapeuticsMD has been recognized with numerous awards, including the Fortune World’s Most Admired Companies 2019 and TIME Magazine’s 2019 list of the World’s 50 Most Innovative Companies.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

TherapeuticsMD
Leadership team

Governor Thomas G. Thompson (Exec. Chairman)

Mr. Hugh O'Dowd M.B.A. (Pres & Director)

Mr. Robert G. Finizio (Co-Founder)

Products/ Services
Biotechnology, Health Care, Medical, Pharmaceutical
Number of Employees
100 - 500
Headquarters
Boca Raton, Florida, United States
Established
2008
Company Registration
SEC CIK number: 0000025743
Revenue
20M - 100M
Traded as
TXMD
Social Media